This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,206.49 fixed-price delivery order is for the supply of a Budesonide-Formoterol medication, which is used to treat respiratory conditions. The contract has an ultimate completion date of December 4, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that broader IDC framework. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contracting experience and capabilities position the company as a key vendor for supplying critical medical commodities to various government agencies and healthcare programs.
Generated 3/4/25, 11:22 AM